MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 204 filers reported holding MEDICINES CO in Q4 2016. The put-call ratio across all filers is 2.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $254,000 | -83.1% | 3,000 | -92.7% | 0.00% | -75.0% |
| Q2 2019 | $1,499,000 | +215.6% | 41,125 | +141.7% | 0.00% | +300.0% |
| Q1 2019 | $475,000 | +2694.1% | 17,013 | +2735.5% | 0.00% | – |
| Q3 2018 | $17,000 | -98.6% | 600 | -98.2% | 0.00% | -100.0% |
| Q3 2017 | $1,205,000 | +361.7% | 32,549 | +373.7% | 0.05% | +345.5% |
| Q2 2017 | $261,000 | -85.2% | 6,871 | -80.9% | 0.01% | -85.5% |
| Q1 2017 | $1,761,000 | +686.2% | 36,020 | +443.8% | 0.08% | +484.6% |
| Q4 2016 | $224,000 | -85.1% | 6,624 | -83.3% | 0.01% | -87.3% |
| Q3 2016 | $1,499,000 | +426.0% | 39,737 | +367.9% | 0.10% | +436.8% |
| Q2 2016 | $285,000 | +60.1% | 8,492 | +77.5% | 0.02% | +35.7% |
| Q4 2015 | $178,000 | -27.3% | 4,784 | -26.1% | 0.01% | -22.2% |
| Q3 2015 | $245,000 | -48.1% | 6,471 | -60.8% | 0.02% | -55.0% |
| Q2 2015 | $472,000 | -13.1% | 16,525 | -14.9% | 0.04% | -36.5% |
| Q1 2015 | $543,000 | +1497.1% | 19,410 | +1462.8% | 0.06% | +1475.0% |
| Q4 2014 | $34,000 | – | 1,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |